Fliegerova K, Mahayri T, Sechovcova H, Mekadim C, Mrazek J, Jarosikova R
Front Microbiol. 2025; 15():1451054.
PMID: 39839113
PMC: 11747157.
DOI: 10.3389/fmicb.2024.1451054.
Trojacka E, Izdebska J, Szaflik J, Przybek-Skrzypecka J
Microorganisms. 2024; 12(11).
PMID: 39597621
PMC: 11596073.
DOI: 10.3390/microorganisms12112232.
Jakubowicz D, Matz Y, Landau Z, Rosenblum R, Twito O, Wainstein J
Int J Mol Sci. 2024; 25(22).
PMID: 39596418
PMC: 11594859.
DOI: 10.3390/ijms252212355.
Niu Q, Li D, Guo W, Feng Z, Han Z, Yang Y
BMC Endocr Disord. 2024; 24(1):184.
PMID: 39256735
PMC: 11386097.
DOI: 10.1186/s12902-024-01691-5.
Xu M, Chen B, Qiao K, Liu S, Su Y, Cai S
Mar Drugs. 2024; 22(8).
PMID: 39195493
PMC: 11355842.
DOI: 10.3390/md22080377.
Circadian Rhythms, the Gut Microbiome, and Metabolic Disorders.
Zhao E, Tait C, Minacapelli C, Catalano C, Rustgi V
Gastro Hep Adv. 2024; 1(1):93-105.
PMID: 39129932
PMC: 11307590.
DOI: 10.1016/j.gastha.2021.10.008.
Microbiota, natural products, and human health: exploring interactions for therapeutic insights.
Qadri H, Shah A, Almilaibary A, Mir M
Front Cell Infect Microbiol. 2024; 14:1371312.
PMID: 39035357
PMC: 11257994.
DOI: 10.3389/fcimb.2024.1371312.
Determination of Bile Acids in Canine Biological Samples: Diagnostic Significance.
Nemeth K, Sterczer A, Sandor Kiss D, Lanyi R, Hemzo V, Vamos K
Metabolites. 2024; 14(4).
PMID: 38668306
PMC: 11052161.
DOI: 10.3390/metabo14040178.
Characterization of the gut bacterial and viral microbiota in latent autoimmune diabetes in adults.
Poulsen C, Hesse D, Fernandes G, Hansen T, Kern T, Linneberg A
Sci Rep. 2024; 14(1):8315.
PMID: 38594375
PMC: 11003976.
DOI: 10.1038/s41598-024-58985-w.
(Vahl) Mast.: Volatile constituents, antioxidant, antidiabetic and wound healing activities of its essential oil.
Khatib S, Mahdi I, Drissi B, Fahsi N, Bouissane L, Sobeh M
Heliyon. 2024; 10(3):e24563.
PMID: 38317922
PMC: 10839871.
DOI: 10.1016/j.heliyon.2024.e24563.
Supplementation of Clostridium butyricum Alleviates Vascular Inflammation in Diabetic Mice.
Zhou T, Qiu S, Zhang L, Li Y, Zhang J, Shen D
Diabetes Metab J. 2024; 48(3):390-404.
PMID: 38310882
PMC: 11140397.
DOI: 10.4093/dmj.2023.0109.
A Comprehensive Review of the Effects of Glycemic Carbohydrates on the Neurocognitive Functions Based on Gut Microenvironment Regulation and Glycemic Fluctuation Control.
Yin J, Cheng L, Hong Y, Li Z, Li C, Ban X
Nutrients. 2023; 15(24).
PMID: 38140339
PMC: 10745758.
DOI: 10.3390/nu15245080.
Clinical value of neutrophil-to-lymphocyte ratio and prognostic nutritional index on prediction of occurrence and development of diabetic foot-induced sepsis.
Sun B, Chen Y, Man Y, Fu Y, Lin J, Chen Z
Front Public Health. 2023; 11:1181880.
PMID: 38026334
PMC: 10630165.
DOI: 10.3389/fpubh.2023.1181880.
From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes.
Widjaja F, Rietjens I
Biomedicines. 2023; 11(10).
PMID: 37893032
PMC: 10603957.
DOI: 10.3390/biomedicines11102658.
Impact of Hypoxia-Hyperoxia Exposures on Cardiometabolic Risk Factors and TMAO Levels in Patients with Metabolic Syndrome.
Bestavashvili A, Glazachev O, Ibragimova S, Suvorov A, Bestavasvili A, Ibraimov S
Int J Mol Sci. 2023; 24(19).
PMID: 37833946
PMC: 10572339.
DOI: 10.3390/ijms241914498.
The Synergism of Human and Inulin Decrease Hyperglycemia via Regulating the Composition of Gut Microbiota and Metabolic Profiles in db/db Mice.
Li P, Tong T, Wu Y, Zhou X, Zhang M, Liu J
J Microbiol Biotechnol. 2023; 33(12):1657-1670.
PMID: 37734909
PMC: 10772568.
DOI: 10.4014/jmb.2304.04039.
Mechanisms of Oxidative Stress in Metabolic Syndrome.
Masenga S, Kabwe L, Chakulya M, Kirabo A
Int J Mol Sci. 2023; 24(9).
PMID: 37175603
PMC: 10178199.
DOI: 10.3390/ijms24097898.
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19.
Talukdar D, Bandopadhyay P, Ray Y, Paul S, Sarif J, DRozario R
Gut Pathog. 2023; 15(1):22.
PMID: 37161621
PMC: 10170741.
DOI: 10.1186/s13099-023-00546-z.
Alterations of the gut microbiota in type 2 diabetics with or without subclinical hypothyroidism.
Lv Y, Liu R, Jia H, Sun X, Gong Y, Ma L
PeerJ. 2023; 11:e15193.
PMID: 37073275
PMC: 10106085.
DOI: 10.7717/peerj.15193.
Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
Kuraji R, Shiba T, Dong T, Numabe Y, Kapila Y
World J Gastroenterol. 2023; 29(6):967-996.
PMID: 36844143
PMC: 9950865.
DOI: 10.3748/wjg.v29.i6.967.